Business Standard

Monday, December 23, 2024 | 12:25 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Cough syrup deaths: Centre, UP team inspect pharma firm's Noida unit

Cough syrup maker linked to Uzbekistan deaths halts production; samples of Dok-1 Max sent for analysis

cough syrup, medicine, cold
Premium

According to news agency ANI, Marion Biotech has halted the production of Dok-1 Max. | Representative/ File Image

Sohini Das Mumbai
A team of drug inspectors from the Centre and the Food Safety and Drug Administration (FSDA) of Uttar Pradesh (UP) visited the Noida facility of Marion Biotech and sent samples for testing. This comes in the aftermath of drug exports from India coming under fire again, with Uzbekistan reporting deaths of 18 children allegedly linked to syrup and tablet consumption of Marion Biotech’s cold medication. Uzbekistan has initiated legal action against the company.

Union Health Minister Mansukh Mandaviya said in a series of tweets that the Central Drugs Standard Control Organisation (CDSCO) has been in regular contact with the national drug

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in